IntrinsicIntrinsic

Mergers & Acquisitions ·

Catheter Precision, Inc. filed an amendment to its March 9, 2026 Form 8-K/A to include audited financial statements…

VTAKFlyte Aviation, Inc.

Catheter Precision, Inc. filed an amendment to its March 9, 2026 Form 8-K/A to include audited financial statements and pro forma information for its acquisition of Fly Flyte, Inc. and Ponderosa Air, LLC. The transaction was completed on March 9, 2026, with Catheter Precision acquiring 100% ownership through a combination of cash, promissory notes, and Series D Preferred Stock issuance. The aggregate purchase price was $11,554,827, comprising approximately $5.8 million in cash (including a $5 million note) and $5.8 million in equity. Pro forma results for the year ended December 31, 2025, show combined revenues of $1.8 million and a net loss of $23.3 million, reflecting transaction costs and purchase accounting adjustments including $10.1 million in goodwill. Catheter Precision operates in the medical device industry.

More from Flyte Aviation, Inc.

Explore VTAK